Showing results (1-10 of 240) with videos related to
Sort By:
Pageof 24
Cellular Immunology|September 1, 1993
Bidirectional modulation of human B cell stimulation by activated T cellsS Hirohata, S ShinoharaThe Journal of Rheumatology|February 1, 1992
Phenotypic analysis of peripheral blood monocytes isolated from patients with rheumatoid arthritisS Shinohara, S Hirohata, T Inoue, et al.Arthritis and Rheumatism|February 1, 1992
Regulation of B cell function by lobenzarit, a novel disease-modifying antirheumatic drugS Hirohata, S Shinohara, T Inoue, et al.Cellular Immunology|December 1, 1992
Role of CD11a/CD18-CD54 interactions in suppression of human B cell responsiveness by CD4+ suppressor T cellsS HirohataCellular Immunology|December 17, 1997
Suppression of human B cell responsiveness by CD4+ T cells does not involve CD95-CD95 ligand interactionsS HirohataClinical Immunology and Immunopathology|November 1, 1996
Inhibition of human B cell activation by gold compoundsS HirohataNihon Rinsho. Japanese Journal of Clinical Medicine|March 17, 1999
[Central nervous system involvement in rheumatic diseases]S HirohataCellular Immunology|January 15, 1998
The role of CD40-CD40 ligand interactions in suppression of human B cell responsiveness by CD4+ T cellsS HirohataClinical and Experimental Rheumatology|July 1, 1992
Regulation of in vitro anti-DNA antibody production by a novel disease modifying anti-rheumatic drug, LobenzaritS HirohataClinical and Experimental Immunology|February 5, 1999
Human Th1 responses driven by IL-12 are associated with enhanced expression of CD40 ligandS HirohataPageof 24